REFERENCES

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49.

2. Campi R, Rebez G, Klatte T, et al. Effect of smoking, hypertension and lifestyle factors on kidney cancer - perspectives for prevention and screening programmes. Nat Rev Urol. 2023;20:669-81.

3. Milella M, Rutigliano M, Lasorsa F, et al. The role of MUC1 in renal cell carcinoma. Biomolecules. 2024;14:315.

4. Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I. J Urol. 2021;206:199-208.

5. Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82:399-410.

6. Pandolfo SD, Cerrato C, Wu Z, et al. A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors. Asian J Urol. 2023;10:390-406.

7. Borghesi M, Brunocilla E, Schiavina R, Martorana G. Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer. 2013;11:5-9.

8. Rakul SA, Pozdnyakov KV, Eloev RA. [Nephron sparing surgery in complex kidney tumors]. Urologiia. 2020;6:99-105.

9. Simone G, De Nunzio C, Ferriero M, et al. Trends in the use of partial nephrectomy for cT1 renal tumors: analysis of a 10-yr European multicenter dataset. Eur J Surg Oncol. 2016;42:1729-35.

10. Pandolfo SD, Wu Z, Campi R, et al. Outcomes and techniques of Robotic-Assisted Partial Nephrectomy (RAPN) for renal hilar masses: a comprehensive systematic review. Cancers. 2024;16:693.

11. Ambani SN, Morgan TM, Montgomery JS, et al. Predictors of delayed intervention for patients on active surveillance for small renal masses: does renal mass biopsy influence our decision? Urology. 2016;98:88-96.

12. Pierorazio PM, Johnson MH, Ball MW, et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur Urol. 2015;68:408-15.

13. Cerrato C, Patel D, Autorino R, et al. Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) collaborative group. World J Urol. 2023;41:747-55.

14. Ferriero M, Brassetti A, Mastroianni R, et al. Off-clamp robot-assisted partial nephrectomy for purely hilar tumors: technique, perioperative, oncologic and functional outcomes from a single center series. Eur J Surg Oncol. 2022;48:1848-53.

15. Cerrato C, Meagher MF, Autorino R, et al. Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group). Minerva Urol Nephrol. 2023;75:425-33.

16. Kim SP, Shah ND, Weight CJ, et al. Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort. J Urol. 2011;186:1779-85.

17. Bertolo R, Autorino R, Fiori C, et al. Expanding the indications of robotic partial nephrectomy for highly complex renal tumors: urologists’ perception of the impact of hyperaccuracy three-dimensional reconstruction. J Laparoendosc Adv Surg Tech A. 2019;29:233-9.

18. Abdel Raheem A, Alatawi A, Kim DK, et al. Outcomes of high-complexity renal tumours with a preoperative aspects and dimensions used for an anatomical (PADUA) score of ≥ 10 after robot-assisted partial nephrectomy with a median 46.5-month follow-up: a tertiary centre experience. BJU Int. 2016;118:770-8.

19. Abedali ZA, Monn MF, Huddleston P, et al. Robotic and open partial nephrectomy for intermediate and high complexity tumors: a matched-pairs comparison of surgical outcomes at a single institution. Scand J Urol. 2020;54:313-7.

20. Altunrende F, Laydner H, Hernandez AV, et al. Correlation of the RENAL nephrometry score with warm ischemia time after robotic partial nephrectomy. World J Urol. 2013;31:1165-9.

21. Rosiello G, Piazza P, Puliatti S, et al. Simplified PADUA renal (SPARE) nephrometry score validation and long-term outcomes after robot-assisted partial nephrectomy. Urol Oncol. 2022;40:65.e1-9.

22. Campi R, Di Maida F, Lane BR, et al; Members of the SIB International Consortium. Impact of surgical approach and resection technique on the risk of Trifecta failure after partial nephrectomy for highly complex renal masses. Eur J Surg Oncol. 2022;48:687-93.

23. Ficarra V, Porpiglia F, Crestani A, et al. The Simplified PADUA REnal (SPARE) nephrometry system: a novel classification of parenchymal renal tumours suitable for partial nephrectomy. BJU Int. 2019;124:621-8.

24. Klein C, Margue G, Champy C, et al. Can Simplified PADUA Renal (SPARE) Nephrometry scoring system help predict renal function outcomes after robot-assisted partial nephrectomy? Minerva Urol Nephrol. 2023;75:569-76.

25. Rivero Belenchón I, Congregado Ruíz CB, Gómez Ciriza G, et al. How to obtain a 3D printed model of renal cell carcinoma (RCC) with venous tumor thrombus extension (VTE) for surgical simulation (phase I NCT03738488). Updates Surg. 2020;72:1237-46.

26. Grosso AA, Di Maida F, Tellini R, et al. Robot-assisted partial nephrectomy with 3D preoperative surgical planning: video presentation of the florentine experience. Int Braz J Urol. 2021;47:1272-3.

27. Bignante G, Orsini A, Lasorsa F, et al. Robotic-assisted surgery for the treatment of urologic cancers: recent advances. Expert Rev Med Devices. 2024;21:1165-77.

28. Bianchi L, Schiavina R, Bortolani B, et al. Interpreting nephrometry scores with three-dimensional virtual modelling for better planning of robotic partial nephrectomy and predicting complications. Urol Oncol. 2021;39:836.e1-9.

29. Amparore D, Piramide F, Pecoraro A, et al. Identification of recurrent anatomical clusters using three-dimensional virtual models for complex renal tumors with an imperative indication for nephron-sparing surgery: new technological tools for driving decision-making. Eur Urol Open Sci. 2022;38:60-6.

30. Grosso AA, Di Maida F, Lambertini L, et al. Three-dimensional virtual model for robot-assisted partial nephrectomy: a propensity-score matching analysis with a contemporary control group. World J Urol. 2024;42:338.

31. Amparore D, Piramide F, Checcucci E, et al. Three-dimensional virtual models of the kidney with colored perfusion regions: a new algorithm-based tool for optimizing the clamping strategy during robot-assisted partial nephrectomy. Eur Urol. 2023;84:418-25.

32. Lasorsa F, Orsini A, Bignante G, et al. Predictors of delayed hospital discharge after robot-assisted partial nephrectomy: the impact of single-port robotic surgery. World J Urol. 2024;43:30.

33. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol. 1999;162:1930-3.

34. Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR. Long-term follow-up after partial removal of a solitary kidney. N Engl J Med. 1991;325:1058-62.

35. Gill IS, Aron M, Gervais DA, Jewett MA. Clinical practice. Small renal mass. N Engl J Med. 2010;362:624-34.

36. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-305.

37. Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007;298:1291-9.

38. Di Maida F, Grosso AA, Sforza S, et al. Surgical management of synchronous, bilateral renal masses: a 1-decade referral center experience. Eur Urol Focus. 2022;8:1309-17.

39. Britton CJ, Sharma V, Lohse CM, et al. Progression of chronic kidney disease following radical and partial nephrectomy. Urology. 2022;169:125-33.

40. Takagi T, Kondo T, Omae K, et al. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease. Int Urol Nephrol. 2016;48:1421-7.

41. Swartling O, Rydell H, Stendahl M, Segelmark M, Trolle Lagerros Y, Evans M. CKD progression and mortality among men and women: a nationwide study in Sweden. Am J Kidney Dis. 2021;78:190-9.e1.

42. Kinsey EN, George D. Can i get a multidisciplinary consult, please? Eur Urol Focus. 2020;6:9-10.

43. Khandwala YS, Jeong IG, Kim JH, et al. The impact of surgeon volume on perioperative outcomes and cost for patients receiving robotic partial nephrectomy. J Endourol. 2017;31:851-7.

44. Khandwala YS, Jeong IG, Han DH, et al. Surgeon preference of surgical approach for partial nephrectomy in patients with baseline chronic kidney disease: a nationwide population-based analysis in the USA. Int Urol Nephrol. 2017;49:1921-7.

45. Alimi Q, Peyronnet B, Sebe P, et al. Comparison of short-term functional, oncological, and perioperative outcomes between laparoscopic and robotic partial nephrectomy beyond the learning curve. J Laparoendosc Adv Surg Tech A. 2018;28:1047-52.

46. Antonelli A, Mari A, Longo N, et al; Collaborators. Role of clinical and surgical factors for the prediction of immediate, early and late functional results, and its relationship with cardiovascular outcome after partial nephrectomy: results from the prospective multicenter RECORd 1 project. J Urol. 2018;199:927-32.

47. Chalouhy C, Ruck JM, Zhou T, et al. Robotic partial nephrectomy in patients with chronic kidney disease: objective measurement of short- and long-term renal functional outcomes. J Endourol. 2018;32:630-4.

48. Clark D, Tauber J, Sheppard J, Brady TC. Early onset and broad activity of reproxalap in a randomized, double-masked, vehicle-controlled phase 2b trial in dry eye disease. Am J Ophthalmol. 2021;226:22-31.

49. Pazeto CL, Macek P, Amaral B, et al. Optimal surgical outcome of minimally invasive partial nephrectomy (MIPN) based on an early postoperative estimated glomerular filtration rate (eGFR). Curr Urol Rep. 2021;22:36.

50. Chandrasekar T, Boorjian SA, Capitanio U, Gershman B, Mir MC, Kutikov A. Collaborative review: factors influencing treatment decisions for patients with a localized solid renal mass. Eur Urol. 2021;80:575-88.

51. Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000;75:1236-42.

52. Simmons MN, Lieser GC, Fergany AF, Kaouk J, Campbell SC. Association between warm ischemia time and renal parenchymal atrophy after partial nephrectomy. J Urol. 2013;189:1638-42.

53. Bruner B, Breau RH, Lohse CM, Leibovich BC, Blute ML. Renal nephrometry score is associated with urine leak after partial nephrectomy. BJU Int. 2011;108:67-72.

54. Rathi N, Palacios DA, Abramczyk E, et al. Predicting GFR after radical nephrectomy: the importance of split renal function. World J Urol. 2022;40:1011-8.

55. Tanaka H, Wang Y, Suk-Ouichai C, et al. Can we predict functional outcomes after partial nephrectomy? J Urol. 2019;201:693-701.

56. Crocerossa F, Fiori C, Capitanio U, et al. Estimated glomerular filtration rate decline at 1 year after minimally invasive partial nephrectomy: a multimodel comparison of predictors. Eur Urol Open Sci. 2022;38:52-9.

57. Saitta C, Afari JA, Autorino R, et al. Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: a multicenter analysis. Urol Oncol. 2023;41:487.e15-23.

58. Pecoraro A, Roussel E, Amparore D, et al. New-onset chronic kidney disease after surgery for localised renal masses in patients with two kidneys and preserved renal function: a contemporary multicentre study. Eur Urol Open Sci. 2023;52:100-8.

59. Tuderti G, Brassetti A, Mastroianni R, et al. Expanding the limits of nephron-sparing surgery: surgical technique and mid-term outcomes of purely off-clamp robotic partial nephrectomy for totally endophytic renal tumors. Int J Urol. 2022;29:282-8.

60. Tuderti G, Mastroianni R, Anceschi U, et al. Assessing the trade-off between the safety and effectiveness of off-clamp robotic partial nephrectomy for renal masses with a high RENAL score: a propensity score-matched comparison of perioperative and functional outcomes in a multicenter analysis. Eur Urol Focus. 2023;9:1037-43.

61. Ferriero M, Bove AM, Tuderti G, et al. Impact of learning curve on perioperative outcomes of off-clamp minimally invasive partial nephrectomy: propensity score matched comparison of outcomes between training versus expert series. Minerva Urol Nephrol. 2021;73:564-71.

62. Flammia RS, Anceschi U, Tuderti G, et al. Development and internal validation of a nomogram predicting 3-year chronic kidney disease upstaging following robot-assisted partial nephrectomy. Int Urol Nephrol. 2024;56:913-21.

63. Bradshaw AW, Autorino R, Simone G, et al. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) collaborative group. BJU Int. 2020;126:114-23.

64. Kopp RP, Mehrazin R, Palazzi KL, et al. Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score. BJU Int. 2014;114:708-18.

65. Veccia A, Falagario U, Martini A, et al. Upstaging to pT3a in patients undergoing partial or radical nephrectomy for cT1 renal tumors: a systematic review and meta-analysis of outcomes and predictive factors. Eur Urol Focus. 2021;7:574-81.

66. Kara Ö, Maurice MJ, Mouracade P, et al. When partial nephrectomy is unsuccessful: understanding the reasons for conversion from robotic partial to radical nephrectomy at a tertiary referral center. J Urol. 2017;198:30-5.

67. van der Mijn JC, Al Hussein Al Awamlh B, Islam Khan A, et al. Validation of risk factors for recurrence of renal cell carcinoma: results from a large single-institution series. PLoS One. 2019;14:e0226285.

68. Capitanio U, Terrone C, Antonelli A, et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol. 2015;67:683-9.

69. Weight CJ, Lieser G, Larson BT, et al. Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol. 2010;58:293-8.

70. Kutikov A, Smaldone MC, Egleston BL, et al. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol. 2011;60:241-8.

71. Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59:543-52.

72. Stroup SP, Palazzi K, Kopp RP, et al. RENAL nephrometry score is associated with operative approach for partial nephrectomy and urine leak. Urology. 2012;80:151-6.

73. Bier S, Aufderklamm S, Todenhöfer T, et al. Prediction of postoperative risks in laparoscopic partial nephrectomy using RENAL, mayo adhesive probability and renal pelvic score. Anticancer Res. 2017;37:1369-73.

74. Wheat JC, Roberts WW, Hollenbeck BK, Wolf JS Jr, Weizer AZ. Complications of laparoscopic partial nephrectomy. Urol Oncol. 2013;31:57-62.

75. Liu ZW, Olweny EO, Yin G, et al. Prediction of perioperative outcomes following minimally invasive partial nephrectomy: role of the R.E.N.A.L nephrometry score. World J Urol. 2013;31:1183-9.

76. Reddy UD, Pillai R, Parker RA, et al. Prediction of complications after partial nephrectomy by RENAL nephrometry score. Ann R Coll Surg Engl. 2014;96:475-9.

77. Tanagho YS, Kaouk JH, Allaf ME, et al. Perioperative complications of robot-assisted partial nephrectomy: analysis of 886 patients at 5 United States centers. Urology. 2013;81:573-9.

78. Potretzke AM, Knight BA, Zargar H, et al. Urinary fistula after robot-assisted partial nephrectomy: a multicentre analysis of 1791 patients. BJU Int. 2016;117:131-7.

79. Malkoc E, Ramirez D, Kara O, et al. Robotic and open partial nephrectomy for localized renal tumors larger than 7 cm: a single-center experience. World J Urol. 2017;35:781-7.

80. Khene ZE, Mazouin C, Larcher A, et al. Predicting complications after robotic partial nephrectomy: back to simplicity. Eur Urol Focus. 2022;8:777-83.

81. Yim K, Aron M, Rha KH, et al. Outcomes of robot-assisted partial nephrectomy for clinical T3a renal masses: a multicenter analysis. Eur Urol Focus. 2021;7:1107-14.

82. Anceschi U, Brassetti A, Tuderti G, et al. Risk factors for progression of chronic kidney disease after robotic partial nephrectomy in elderly patients: results from a multi-institutional collaborative series. Minerva Urol Nephrol. 2022;74:452-60.

83. Borghesi M, Schiavina R, Gan M, Novara G, Mottrie A, Ficarra V. Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses. World J Urol. 2013;31:499-504.

84. Basatac C, Akpinar H. ‘Trifecta’ outcomes of robot-assisted partial nephrectomy: results of the ‘low volume’ surgeon. Int Braz J Urol. 2020;46:943-9.

85. Lasorsa F, Bignante G, Orsini A, et al. Partial nephrectomy in elderly patients: a systematic review and analysis of comparative outcomes. Eur J Surg Oncol. 2024;50:108578.

86. Iossa V, Pandolfo SD, Buonopane R, et al. Robot-assisted partial nephrectomy vs. percutaneous cryoablation for T1a renal tumors: a single-center retrospective analysis of outcomes and costs. Int Urol Nephrol. 2024;Online ahead of print.

87. Campi R, Grosso AA, Lane BR, et al; SIB International Consortium. Impact of Trifecta definition on rates and predictors of “successful” robotic partial nephrectomy for localized renal masses: results from the surface-intermediate-base margin score international consortium. Minerva Urol Nephrol. 2022;74:186-93.